JP2019514411A5 - - Google Patents

Download PDF

Info

Publication number
JP2019514411A5
JP2019514411A5 JP2018559273A JP2018559273A JP2019514411A5 JP 2019514411 A5 JP2019514411 A5 JP 2019514411A5 JP 2018559273 A JP2018559273 A JP 2018559273A JP 2018559273 A JP2018559273 A JP 2018559273A JP 2019514411 A5 JP2019514411 A5 JP 2019514411A5
Authority
JP
Japan
Prior art keywords
recombinant protein
protein
antigen
altered
galactosylation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018559273A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019514411A (ja
JP6882339B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2017/061181 external-priority patent/WO2017194605A1/en
Publication of JP2019514411A publication Critical patent/JP2019514411A/ja
Publication of JP2019514411A5 publication Critical patent/JP2019514411A5/ja
Application granted granted Critical
Publication of JP6882339B2 publication Critical patent/JP6882339B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018559273A 2016-05-10 2017-05-10 ペルアセチルガラクトースを使った組換えタンパク質のタンパク質ガラクトシル化プロファイルを改変する方法 Active JP6882339B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16169062 2016-05-10
EP16169062.3 2016-05-10
PCT/EP2017/061181 WO2017194605A1 (en) 2016-05-10 2017-05-10 Methods for modulating protein galactosylation profiles of recombinant proteins using peracetyl galactose

Publications (3)

Publication Number Publication Date
JP2019514411A JP2019514411A (ja) 2019-06-06
JP2019514411A5 true JP2019514411A5 (enExample) 2020-06-18
JP6882339B2 JP6882339B2 (ja) 2021-06-02

Family

ID=56026651

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018559273A Active JP6882339B2 (ja) 2016-05-10 2017-05-10 ペルアセチルガラクトースを使った組換えタンパク質のタンパク質ガラクトシル化プロファイルを改変する方法

Country Status (9)

Country Link
US (1) US11118208B2 (enExample)
EP (1) EP3455363B1 (enExample)
JP (1) JP6882339B2 (enExample)
CN (1) CN109072273B (enExample)
AU (2) AU2017264541A1 (enExample)
CA (1) CA3022769A1 (enExample)
ES (1) ES2908067T3 (enExample)
IL (1) IL262875B (enExample)
WO (1) WO2017194605A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017117218A1 (en) 2015-12-30 2017-07-06 Momenta Pharmaceuticals, Inc. Methods related to biologics
EP3824906A1 (en) 2016-12-21 2021-05-26 Amgen Inc. Anti-tnf alpha antibody formulations
MX2021008030A (es) * 2018-12-31 2021-08-05 Momenta Pharmaceuticals Inc Metodos para producir ustekinumab.
CN113549667A (zh) * 2021-07-21 2021-10-26 杭州奕安济世生物药业有限公司 一种降低抗体半乳糖基化的方法
WO2023161885A1 (en) * 2022-02-25 2023-08-31 Kashiv Biosciences, Llc A process for improving polypeptide expression in mammalian cell culture

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102076865B (zh) * 2008-05-02 2016-03-16 西雅图基因公司 用于制造核心岩藻糖基化降低的抗体和抗体衍生物的方法和组合物
WO2012019165A2 (en) * 2010-08-05 2012-02-09 Seattle Genetics, Inc. Methods of inhibition of protein fucosylation in vivo using fucose analogs
CA2943667C (en) * 2014-01-29 2022-11-08 Lg Life Sciences Ltd. Method for modulating galactosylation of recombinant protein through optimization of culture medium
WO2016022377A2 (en) * 2014-08-05 2016-02-11 Abbvie Inc. Methods for modulating the glycosylation profile of recombinant proteins using dissolved oxygen

Similar Documents

Publication Publication Date Title
JP2019514411A5 (enExample)
AR132549A2 (es) Medio de cultivo para células cho libre de suero que comprende ornitina y putrescina, método para cultivar células cho y método in vitro para producir una proteína
CN103827292B (zh) 哺乳动物细胞培养
EP4295911A2 (en) Humanized anti-complement factor c1q antibodies and uses thereof
JP2009502167A5 (enExample)
EA031652B1 (ru) Способ и система для обработки клеточной культуры
RU2013152982A (ru) Способ снижения гетерогенности антител и способ получения соответствующих антител
JP6499660B2 (ja) 不死化ブタ肺胞マクロファージ
JP2019514417A (ja) グルタミンシンセターゼ遺伝子内相補ベクターを用いた高レベルのヘテロマータンパク質発現細胞の直接選択
JP2016526385A (ja) モノクローナル抗体の改良された産生方法
JP2017520242A5 (enExample)
EP3152318A1 (en) Cell culture process for producing a protein
CR20200507A (es) Composiciones aav, métodos de fabricación y métodos de uso
JP2016513478A5 (enExample)
US20230047549A1 (en) An apparatus and a method for continuously harvesting a biological substance produced by a cultured cell
JP2019500876A5 (enExample)
JP2016531581A5 (enExample)
DE602004025011D1 (de) Verfahren zur herstellung rekombinanter proteine
ATE517633T1 (de) Neues verfahren und zusammensetzung zur herstellung einer zellulären allogenen vakzine
CA2738176A1 (en) Method for polyclonal immunoglobulin g production by human b cells
US20210222109A1 (en) Methods of continuous cell culture
WO2019070435A8 (en) Methods for selectively expanding cells expressing a tcr with a murine constant region
JPWO2022019306A5 (enExample)
JP2020519265A5 (enExample)
CN104004814A (zh) 采用动物细胞流加培养方式精确控制单克隆抗体产品质量的方法